$1.17
0.021.74%
Last update: 9:53 AM
15 minutes delayed
Kronos Bio
KRONNASDAQ
want to know what
the Bulls & Bears Say?
Kronos Bio (NASDAQ:KRON) Stock, Analyst Ratings, Price Targets, Forecasts
Kronos Bio Inc has a consensus price target of $8.56 based on the ratings of 14 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co. on May 3, 2024, December 19, 2023, and December 19, 2023, respectively. With an average price target of $3.58 between HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co., there's an implied 224.14% upside for Kronos Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Piper Sandler
Goldman Sachs
Berenberg
1calculated from analyst ratings
Analyst Ratings for Kronos Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/03/2024 | Buy Now | 103.53% | HC Wainwright & Co. | Robert Burns | $2.5 → $2.25 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | 442.74% | Piper Sandler | Edward Tenthoff | $7 → $6 | Maintains | Overweight | Get Alert |
| 12/19/2023 | Buy Now | 126.14% | HC Wainwright & Co. | Robert Burns | $9 → $2.5 | Maintains | Buy | Get Alert |
| 11/27/2023 | Buy Now | 714.11% | HC Wainwright & Co. | Robert Burns | → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | Buy Now | 714.11% | HC Wainwright & Co. | Robert Burns | $10 → $9 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 804.57% | HC Wainwright & Co. | Robert Burns | → $10 | Reiterates | → Buy | Get Alert |
| 11/18/2022 | Buy Now | 804.57% | HC Wainwright & Co. | Robert Burns | $36 → $10 | Maintains | Buy | Get Alert |
| 11/10/2022 | Buy Now | 1166.4% | Goldman Sachs | Salveen Richter | $25 → $14 | Maintains | Buy | Get Alert |
| 11/09/2022 | Buy Now | 533.2% | Piper Sandler | Edward Tenthoff | $13 → $7 | Maintains | Overweight | Get Alert |
| 09/14/2022 | Buy Now | 985.48% | Berenberg | Zhiqiang Shu | → $12 | Initiates | → Buy | Get Alert |
| 05/24/2022 | Buy Now | 1980.51% | Goldman Sachs | Salveen Richter | $35 → $23 | Maintains | Buy | Get Alert |
| 05/23/2022 | Buy Now | 1075.94% | Piper Sandler | Edward Tenthoff | $30 → $13 | Maintains | Overweight | Get Alert |
| 02/28/2022 | Buy Now | 2613.7% | Piper Sandler | Edward Tenthoff | $50 → $30 | Maintains | Overweight | Get Alert |
| 11/10/2021 | Buy Now | 3156.45% | HC Wainwright & Co. | Robert Burns | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Kronos Bio (KRON) stock?
The latest price target for Kronos Bio (NASDAQ:KRON) was reported by HC Wainwright & Co. on May 3, 2024. The analyst firm set a price target for $2.25 expecting KRON to rise to within 12 months (a possible 92.31% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kronos Bio (KRON)?
The latest analyst rating for Kronos Bio (NASDAQ:KRON) was provided by HC Wainwright & Co., and Kronos Bio maintained their buy rating.
When was the last upgrade for Kronos Bio (KRON)?
There is no last upgrade for Kronos Bio
When was the last downgrade for Kronos Bio (KRON)?
There is no last downgrade for Kronos Bio.
When is the next analyst rating going to be posted or updated for Kronos Bio (KRON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kronos Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kronos Bio was filed on May 3, 2024 so you should expect the next rating to be made available sometime around May 3, 2025.
Is the Analyst Rating Kronos Bio (KRON) correct?
While ratings are subjective and will change, the latest Kronos Bio (KRON) rating was a maintained with a price target of $2.50 to $2.25. The current price Kronos Bio (KRON) is trading at is $1.17, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.